Candriam SCA’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-39,158
Closed -$2.81M 719
2024
Q1
$2.81M Hold
39,158
0.02% 449
2023
Q4
$7.78M Hold
39,158
0.05% 287
2023
Q3
$5.21M Hold
39,158
0.04% 306
2023
Q2
$5.86M Sell
39,158
-2,142
-5% -$320K 0.04% 313
2023
Q1
$5.58M Buy
41,300
+2,142
+5% +$289K 0.04% 341
2022
Q4
$6.2M Hold
39,158
0.04% 346
2022
Q3
$7.54M Buy
39,158
+6,110
+18% +$1.18M 0.05% 320
2022
Q2
$4.83M Buy
33,048
+13,327
+68% +$1.95M 0.04% 327
2022
Q1
$3.47M Buy
+19,721
New +$3.47M 0.02% 422